These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease. Suichi T, Misawa S, Sekiguchi Y, Shibuya K, Tsuneyama A, Suzuki YI, Nakamura K, Kano H, Kuwabara S. J Neurol Sci; 2020 Jun 15; 413():116771. PubMed ID: 32172013 [Abstract] [Full Text] [Related]
23. Serum vascular endothelial growth factor (VEGF) in the differential diagnosis of amyloid neuropathy and POEMS syndrome. Econimo L, Jeannin G, Biasi L, Mazzola G, Mendeni M, Presteni K, Gregorini G. Amyloid; 2011 Jun 15; 18 Suppl 1():106-8. PubMed ID: 21838451 [No Abstract] [Full Text] [Related]
24. POEMS syndrome: importance of the clinical laboratory practitioner's role. Levinson SS. Clin Chim Acta; 2012 Nov 12; 413(21-22):1800-7. PubMed ID: 22771968 [Abstract] [Full Text] [Related]
25. [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome]. Kanamori T, Kusumoto S, Okita K, Hagiwara S, Kato C, Nakashima T, Murakami S, Narita T, Ito A, Ri M, Ishida T, Komatsu H, Matsukawa N, Iida S. Rinsho Ketsueki; 2018 Nov 12; 59(2):161-166. PubMed ID: 29515067 [Abstract] [Full Text] [Related]
26. POEMS Syndrome: Diagnosis and Investigative Work-up. Dispenzieri A, Kourelis T, Buadi F. Hematol Oncol Clin North Am; 2018 Feb 12; 32(1):119-139. PubMed ID: 29157614 [Abstract] [Full Text] [Related]
27. Free light chains and heavy/light chains in monitoring POEMS patients. Altinier S, Proko K, Zaninotto M, Ciubotaru D, Seguso M, Varagnolo M, Lessi F, Briani C, Adami F, Plebani M. Clin Chem Lab Med; 2016 Jun 01; 54(6):1065-71. PubMed ID: 27071150 [Abstract] [Full Text] [Related]
28. Increase of serum vascular endothelial growth factors in wet beriberi: two case reports. Imai N, Kubota M, Saitou M, Yagi N, Serizawa M, Kobari M. Intern Med; 2012 Jun 01; 51(8):929-32. PubMed ID: 22504253 [Abstract] [Full Text] [Related]
31. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Kanai K, Kuwabara S, Misawa S, Hattori T. Intern Med; 2007 Jun 01; 46(6):311-3. PubMed ID: 17380000 [Abstract] [Full Text] [Related]
32. [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome]. Adams D, Lozeron P, Theaudin M, Ribrag V, Bourhis JH, Lacroix C. Rev Neurol (Paris); 2011 Jan 01; 167(1):57-63. PubMed ID: 21190703 [Abstract] [Full Text] [Related]
33. Glomeruloid haemangioma: a possible consequence of elevated VEGF in POEMS and Erdheim-Chester disease. Legendre P, Norkowski E, Le Pelletier F, Miyara M, Choquet S, Haroche J, Brocheriou I, Barete S. Eur J Dermatol; 2018 Dec 01; 28(6):784-789. PubMed ID: 30563806 [Abstract] [Full Text] [Related]
34. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. Li J, Huang XF, Cai QQ, Wang C, Cai H, Zhao H, Zhang L, Cao XX, Gale RP, Zhou DB. Am J Hematol; 2018 Jun 01; 93(6):803-809. PubMed ID: 29603764 [Abstract] [Full Text] [Related]
36. [Diagnostic performance and clinical correlation of serum vascular endothelial growth factor levels in patients with newly diagnosed POEMS syndrome]. Cao X, Wang C, Cai H, Duan M, Zhang W, Li T, Zhou D, Li J. Zhonghua Xue Ye Xue Za Zhi; 2014 Dec 01; 35(12):1065-8. PubMed ID: 25543698 [Abstract] [Full Text] [Related]
37. Primary cutaneous diffuse large B-cell lymphoma, leg type, with features simulating POEMS syndrome. Nakayama S, Yokote T, Kobayashi K, Hirata Y, Akioka T, Miyoshi T, Oka S, Hiraoka N, Iwaki K, Takayama A, Takubo T, Tsuji M, Hanafusa T. Eur J Haematol; 2010 Jan 01; 84(1):79-83. PubMed ID: 19558504 [Abstract] [Full Text] [Related]